These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15523292)

  • 1. [The interest of statins in nephrology].
    Massy ZA; Andréjak M
    Presse Med; 2004 Oct; 33(17):1207-12. PubMed ID: 15523292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant].
    Karie S; Launay-Vacher V; Deray G; Isnard-Bagnis C
    Presse Med; 2006 Feb; 35(2 Pt 1):219-29. PubMed ID: 16493350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease in patients with renal disease: the role of statins.
    Fellström B; Holdaas H; Jardine AG; Svensson MK; Gottlow M; Schmieder RE; Zannad F;
    Curr Med Res Opin; 2009 Jan; 25(1):271-85. PubMed ID: 19210158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of statins in chronic kidney disease.
    Kalaitzidis RG; Elisaf MS
    Am J Nephrol; 2011; 34(3):195-202. PubMed ID: 21791915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins for treatment of dyslipidemia in chronic kidney disease.
    Shurraw S; Tonelli M
    Perit Dial Int; 2006; 26(5):523-39. PubMed ID: 16973506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Palmer SC; Navaneethan SD; Craig JC; Perkovic V; Johnson DW; Nigwekar SU; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD005019. PubMed ID: 24470059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins, inflammation and kidney disease.
    Krane V; Wanner C
    Nat Rev Nephrol; 2011 May; 7(7):385-97. PubMed ID: 21629228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL-cholesterol lowering and renal outcomes.
    Waters DD
    Curr Opin Lipidol; 2015 Jun; 26(3):195-9. PubMed ID: 25887677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin therapy in patients with chronic kidney disease: to use or not to use.
    Steinmetz OM; Panzer U; Stahl RA; Wenzel UO
    Eur J Clin Invest; 2006 Aug; 36(8):519-27. PubMed ID: 16893373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Navaneethan SD; Pansini F; Perkovic V; Manno C; Pellegrini F; Johnson DW; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007784. PubMed ID: 19370693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease.
    Navaneethan SD; Hegbrant J; Strippoli GF
    Curr Opin Nephrol Hypertens; 2011 Mar; 20(2):146-52. PubMed ID: 21245764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.
    Kanbay M; Turgut F; Covic A; Goldsmith D
    J Nephrol; 2009; 22(5):598-609. PubMed ID: 19809992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based statin prescription for cardiovascular protection in renal impairment.
    Fabbian F; De Giorgi A; Pala M; Tiseo R; Manfredini R; Portaluppi F
    Clin Exp Nephrol; 2011 Aug; 15(4):456-63. PubMed ID: 21556807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?
    Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
    Expert Opin Pharmacother; 2015; 16(10):1449-61. PubMed ID: 26037614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins in chronic kidney disease: cardiovascular risk and kidney function.
    Deedwania PC
    Postgrad Med; 2014 Jan; 126(1):29-36. PubMed ID: 24393749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease and statins: improving cardiovascular outcomes.
    Walker DB; Walker TJ; Jacobson TA
    Curr Atheroscler Rep; 2009 Jul; 11(4):301-8. PubMed ID: 19500494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins and lipid-lowering strategies in cardiorenal patients.
    Bianchi S; Grimaldi D; Bigazzi R
    Contrib Nephrol; 2011; 171():143-150. PubMed ID: 21625103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials.
    Chan DT; Irish AB; Dogra GK; Watts GF
    Atherosclerosis; 2008 Feb; 196(2):823-34. PubMed ID: 17343861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.